comparison of Misoprostol with Oxytocin on labor augmentation in pregnant wome
Early Phase 1
- Conditions
- ong labour.Prolonged second stage (of labour)
- Registration Number
- IRCT2012102910068N2
- Lead Sponsor
- Shahid Beheshti University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 250
Inclusion Criteria
pregnancy between 36 and 42 weeks of gestation; a live singleton fetus in cephalic presentation; no history of uterine surgery; spontaneous onset of active labor with regular contractions; an effaced cervix dilated between 3 cm and 9 cm; a reassuring fetal heart rate (FHR) pattern.
Exclusion criteria:
nonreassuring FHR pattern; parity greater than five; any contraindication to labor or vaginal delivery or both; epidural analgesia; significant maternal cardiac; renal or hepatic disease; hypersensitivity to misoprostol or prostaglandin analogues.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time from augmentation to vaginal delivery. Timepoint: 12 and 24 hours during labor. Method of measurement: data recording.;Mode of delivery. Timepoint: 12 and 24 hours during labor. Method of measurement: data recording.
- Secondary Outcome Measures
Name Time Method Fetal and neonatal status. Timepoint: peri labor phase. Method of measurement: data record.;Maternal complications. Timepoint: peri labor phase. Method of measurement: data record.